ARTICLE | Company News
Ivax, Ferrer deal
November 1, 2004 8:00 AM UTC
IVAX and Grupo Ferrer partnered to develop citicoline, an oral neuroprotective therapy to treat stroke. Under the deal, IVAX will be responsible for regulatory approval in the U.S. The compound is mar...